Research
13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study
-
* Corresponding author: Barbara Jarzab bjarzab@io.gliwice.pl
1 Department of Nuclear Medicine, Maria Sklodowska-Curie Memorial Institute, Gliwice Branch, Wybrzeza Armii Krajowej 14, 44-100 Gliwice, Poland
2 Department of Endocrine Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice Branch, Wybrzeza Armii Krajowej 14, 44-100 Gliwice, Poland
3 Department of Surgical Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice Branch, Wybrzeza Armii Krajowej 14, 44-100 Gliwice, Poland
Thyroid Research 2009, 2:8 doi:10.1186/1756-6614-2-8
Published: 1 August 2009Additional files
Additional file 1:
Thyroglobulin before and after 13-CRA RDT. The data provided represent thyroglobulin concentration (ng/ml) before and after redifferentiation therapy in all 53 treated patients.
Format: DOC Size: 100KB Download file
This file can be viewed with: Microsoft Word Viewer
